Biotransformation of cyclocanthogenol by the endophytic fungus Alternaria eureka 1E1BL1 by Ekiz, Güner et al.
lable at ScienceDirect
Phytochemistry 151 (2018) 91e98Contents lists avaiPhytochemistry
journal homepage: www.elsevier .com/locate/phytochemBiotransformation of cyclocanthogenol by the endophytic fungus
Alternaria eureka 1E1BL1
Güner Ekiz a, Seda Duman b, Erdal Bedir b, *
a Department of Pharmacognosy, Faculty of Pharmacy, Near East University, Nicosia, Mersin 10, Turkey
b Department of Bioengineering, Faculty of Engineering, Izmir Institute of Technology, 35430 Urla-Izmir, Turkeya r t i c l e i n f o
Article history:
Received 15 November 2017
Received in revised form
31 March 2018
Accepted 9 April 2018
Available online 17 April 2018
Keywords:
Astragalus
Fabaceae
Biotransformation
Cycloartanes
Cyclocanthogenol
Endophytic fungus
Alternaria eureka* Corresponding author.
E-mail address: erdalbedir@iyte.edu.tr (E. Bedir).
https://doi.org/10.1016/j.phytochem.2018.04.006
0031-9422/© 2018 Elsevier Ltd. All rights reserved.a b s t r a c t
The microbial transformation of cyclocanthogenol (CCG), Astragalus sp. originated sapogenin, by the
endophytic fungus Alternaria eureka 1E1BL1 isolated from Astragalus angustifolius was investigated.
Hydroxylation, oxidation, epoxidation, O-methylation, ring-expansion and methyl migration reactions
were observed on the triterpenoid skeleton. As a result, eight metabolites were isolated and the struc-
tures of the previously undescribed compounds were established by 1-D, 2-D NMR and HR-MS analyses.
© 2018 Elsevier Ltd. All rights reserved.1. Introduction
Biotransformation is chemical modifications that occur when
enzymes or whole cell systems are used as catalysts (Borges et al.,
2009; de Carvalho, 2011, 2016). This is a useful method for pro-
duction of new potent molecules, overcoming the problems asso-
ciated with chemical synthesis reactions/enhancement of the
productivity and providing the basic information needed to eluci-
date the biosynthetic pathways. Producing large amounts of
biomass and having great enzyme diversity with chemo-, regio-
and enantio-selective catalytic abilities make microbial systems
logical choice for biotransformation studies (Carballeira et al.,
2009; Pimentel et al., 2011; Tao and Xu, 2009). Whole-cell bio-
catalysis is expected to play a significant role in this growing area of
pharmaceutical industry (Lam, 2009). According to the literature,
microbial transformation is one of the most commonly used
method for transformation of saponins to obtain more active de-
rivatives (Shah et al., 2014; Vincken et al., 2007). Filamentous fungi
have been one of the most studied whole cell systems for
biotransformation reactions. Recently, endophytic fungi havereceived great attention due to their ability to transform complex
natural products with a high degree of stereospecificity. Consid-
ering the fact that endophytes continuously interact with their
hosts via special enzymes and chemicals, they may be promising
source of biocatalyst with numerous application (Bianchini et al.,
2015; Borges et al., 2009; Ludwig-Müller, 2015; Wang and Dai,
2011). However, utilization of the plants' own endophytes to
transform plants' own secondary metabolites have been scarcely
explored in the field of biotransformation.
The genus Astragalus (Fabaceae) is one of the richest sources of
cycloartanes, the unique triterpenoids with a characteristic 9,19-
cyclopropane ring. Cycloartane-type saponins from Astragalus
species have exhibited wide range of biological activities including
wound healing, immunomodulatory, antineoplastic, hep-
atoprotective, antimutagenic, antiviral and antiprotozoal activities
(Çalıs¸ et al., 1997; €Ozipek et al., 2005; Nalbantsoy et al., 2011).
Cycloastragenol, the main sapogenol of many cycloartane-type
glycosides found in Astragalus genus, has attracted great attention
as a telomerase activator which was discovered in a systematic
screening studies of natural product extracts from traditional Chi-
nese medicines (Harley et al., 2010).
Not only potency of cyloartanes as telomerase activators but also
the absence of endophytic fungi's utilization in biotransformation
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continuation of our previous efforts (Kuban et al., 2010, 2013; Tag
et al., 2012; Bedir et al., 2015), we performed microbial trans-
formation on Astragalus cycloartanes by using endophytic fungi
isolated from Astragalus species. In this study, cyclocanthogenol
(CCG), one of the major sapogenins in Astragalus genus, was sub-
jected to biotransformation by fungal endophyte Alternaria eureka
(Pleosporaceae) 1E1BL1. Herein, we report isolation and structural
elucidation of eight (1e8) biotransformation products with diverse
chemistry.2. Results and discussion
A total of 15 endophytic fungi, isolated from the roots, stems and
leaves of Astragalus plants, were screened by TLC for their ability to
transform CCG into previously undescribed derivatives. Based on
the preliminary screening results, the endophytic isolate identified
as Alternaria eureka 1E1BL1 was selected for further biotransfor-
mation studies. Analytical scale biotransformation was performed
to determine the optimal harvesting time of the fungus for trans-
formation of the starting compound. Preparative scale biotrans-
formation of CCG with A. eureka 1E1BL1 for 10 days yielded seven
previously undescribed metabolites 1e7, along with the known
compound 8 (Fig. 1). The structures of 1e8 were characterized by
HR-MS, 1D-, and 2D-NMR data.
Compounds 1, 2 and 3weremonohydroxylated products of CCG.Fig. 1. Transformation productsThe HR-MS data of compound 1 (m/z 531.3664 [MþNa]þ, calcd for
C30H52O6Na, 531.3661) supported a molecular formula C30H52O6,
implying a monohydroxylation of the starting compound. In the 1H
NMR spectrum, the AX system signals of cyclopropane ring, seven
methyl groups in the up-field region, and the characteristic signals
belonging to the H-3, H-6, H-16 and H-24 oxymethine protons in
the low-field displayed no significant discrepancy compared to
CCG. Apart from the characteristic low-field signals, an additional
oxymethine signal at d 3.82 was observed corresponding to a car-
bon at d 73.7 in the HSQC spectrum. The 13C NMR spectrum of 1
showed that C-11 (d 39.7) and C-13 (d 50.5) signals had undergone a
significant down-field shift (ca. 16 and 5 ppm, respectively) when
compared to that of CCG, suggesting a hydroxylation at C-12 posi-
tion. This assumption was confirmed with the long-distance cor-
relations in the HMBC spectrum from d 3.82 to C-13, C-14 and C-18,
and H-11 and H-18 to d 73.7. In order to establish the stereo-
chemistry at C-12, a 2D-NOESY experiment was performed. The
nOe correlation between H-12 and b-oriented H3-18 indicated the
a-configuration of 12-OH. On the basis of these results, the struc-
ture of 1 was established as 3b,6a,12a,16b,24(S),25-
hexahydroxycycloartane.
The HR-MS spectrum of 2 showed a major ion peak at m/z
531.3679 [MþNa]þ (C30H52O6Na). Like 1, compound 2 displayed the
9,19-cyclopropane ring signals of CCG, seven methyl groups, and
the signals belonging to the H-3, H-6, H-16 and H-24 oxymethine
protons. The signal observed at d 4.04 suggested anotherof cyclocanthogenol (CCG).
Fig. 3. Key long-range correlations (HMBC) of 3.
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spectrum. A detailed inspection of the 13C NMR spectrum showed
down-field shift for C-20 and C-23 signals (ca. 12 ppm) when
compared to that of CCG, therefore, a hydroxylation at C-22 was
suggested. In the COSY spectrum, the partial identification of the
side-chain spin system starting from the distinct H-24 proved this
suggestion [H-24 (d 3.53 dd, J¼ 10.5, 2.2 Hz) / H2-23 (1.58m,
1.77m)/H-22 (d 4.04 dd, J¼ 7.3, 5.8 Hz)] (Fig. 2). Furthermore, the
key long correlations observed in the HMBC spectrum fromH-22 to
C-24, and fromH-21/H2-23 to C-22 justified the hydroxylation at C-
22. Based on the NOESY data, one of the intriguing observation in
the COSY spectrum was missing 3JH-H coupling between H-22 and
H-20. This data implied that somehow the side chainwas not freely
rotating to adopt different conformers setting the dihedral angle of
the H-20/C-20/C-22/H-20 system to be about 90. Therefore it was
proposed that the conformational flexibility was prohibited due to
a couple of hydrogen bond formations in a hydroxyl group rich
vicinity (C-16, C-22, C-24 and C-25). To confirm this hypothesis and
stereochemistry of C-22, minimized energy conformers of 2 were
calculated by MM2 molecular mechanics program. Although an
appropriate dihedral bond angle was reached with 22(S) absolute
configuration revealing hydrogen bonds between side chain OH
groups [C-22(OH)/C24(OH) and C-24(OH)/C25(OH)], the observed
ROESY correlations did imply free rotation in the side chain. The
determination of the configuration of the stereocenter C-22 was
not possible. On the basis of these results, the structure of 2 was
established as 3b,6a,16b,22,24(S),25-hexahydroxycycloartane.
The HR-MS data of compound 3 (m/z 531.3672 [MþNa]þ, calcd
for C30H52O6Na, 531.3661) displayed 16 amu increase over the
starting compound, implying monohydroxylation. The signals of
9,19-cyclopropane ring and seven methyl groups, and H-3, H-6, H-
16 and H-24 resonances were observed readily in the 1H NMR
spectrum as in 1 and 2. In the 13C NMR spectrum, apart from the C-
3, C-6, C-16, C-24 and C-25 oxygenated carbons, an additional
signal at d 89.3 was observed. In the HSQC spectrum, no correlation
of this carbon with any proton indicated its quaternary nature. The
d 89.3 resonance was unambiguously assigned to C-17 based on the
long-distance correlations in the HMBC from H-16, H-15a, H3-18
and H3-21 protons to d 89.3 (Fig. 3). Additionally, down-field shifts
of C-16, C-14 and C-20 signals substantiated the hydroxylation
position. A thorough literature search on biotransformation me-
tabolites of the steroidal compounds proposed a single configura-
tion for C-17(OH) to be alpha. However, to establish the orientation
unambiguously, NMR spectrum of 3was recorded in pyridine-d5 to
observe the exchangeable proton of C-17(OH). Based on the 3JC-H
HMBC correlations between the exchangeable proton at d 4.83 (s)
and C-16/C-13, 17(OH) was readily located. In the 2D-ROESY spec-
trum, cross peaks from this exchangeable proton to the axial H-12aFig. 2. The partial spin systems (COSY) and keyproton (d 2.58, t, 11.8 Hz), and from the latter to H3-30 exhibited
that all these protons were cofacial with alpha orientation. Thus,
the structure of 3 was identified as 3b,6a,16b,17a,24(S),25-
hexahydroxycycloartane.
The molecular formula of compound 4 was established as
C30H46O6 by HR-MS analysis (m/z 525.3206 [MþNa]þ, calcd for
C30H46O6Na, 525.3192). In the 1H NMR spectrum, the disappear-
ance of the AX system signals deriving from 9,19-cyclopropane ring
suggested a ring cleavage. The hydroxymethine proton at C-16 was
not present in the 1H NMR spectrum. In addition, a new doublet
signal at d 4.03 was observed together with two olefinic protons (d
5.46 and 5.68). In the 13C NMR spectrum, apart from the C-3, C-6, C-
24 and C-25 oxygenated carbons, two additional signals at d 72.3
and 88.3 were detected. The 13C NMR spectrum of 4 also exhibited
four olefinic carbon resonances (d 128.4, 134.2, 136.8 and 141.8) and
a carbonyl signal at d 221.4. The combined use of DQF-COSY and
HSQC spectra, allowed the assignment of two spin systems (Fig. 2):
‘A’ (H-3/ H2-1) and ‘B‘(H-5/ H2-19). The spin system A includes
the H-3 resonance (d 3.73 d, J¼ 5.6 Hz) which showed correlation
with H-2b (d 1.74m), while the latter proton showed cross peak
with H-2a (d 2.00m), which, in turn, coupled with both H2-1 pro-
tons (d 1.38m and 1.58m). The second spin system (B) includes a
methine proton at d 1.61 (m, H-5) which showed correlation with
the oxymethine proton at C-6 (d 4.54 dd, J¼ 10.3, 3.4 Hz) and from
there to an olefinic methine proton at d 5.46 (dd, J¼ 3.5, 1.3 Hz, H-
7). The H-7 proton showed 5JH-H coupling with H-11 through the
conjugated double bond system (d 5.68 d, J¼ 5.5 Hz) in the DQF-
COSY spectrum. H-11 coupled with oxymethine proton at d 4.03
(d, J¼ 6.0 Hz, H-12) which, in turn, exhibited cross peaks with the
H2-19methylene protons (d 2.67 d, J¼ 14.3 Hz; d 3.04 d, J¼ 14.0 Hz).
Location of the olefinic double bonds was assigned from the cor-
relations in the HMBC spectrum. The two signals (d 2.67 and 3.04)long-range correlations (HMBC) of 2 and 4.
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the HMBC spectrum (d 2.67 to C-5, C-10, C-11, C-9 and C-8; d 3.04 to
C-10, C-11 and C-9) indicating a seven-membered B ring resulting
from the cleavage of the cyclopropane ring. The long-distance
correlations from H2-19, H-12 and H-7 to the quaternary carbon
at d 134.2 revealed the location of the double bond between C-9 and
C-11. The other trisubstituted double bond was positioned between
C-7 and C-8 based on the HMBC correlations from H-19b, H-11 and
H3-30 to the quaternary 141.8 ppm signal. Additionally, the carbon
signal at d 221.4 displayed long-range correlations with the protons
of H2-15 and H-17, implying the oxidation of C-16 secondary
alcohol to a ketone. On the other hand, a new signal observed at
d 4.03, corresponding with a carbon at 72.3 ppm in the HSQC
spectrum, indicated an additional oxymethine group. The HMBC
spectrum showed long-distance correlations from d 4.03 proton to
C-9, C-11, C-14. Based on these findings, the new hydroxyl group
was located at C-12. The hydroxyl group at C-12 was deduced to be
a-oriented on the basis of ROESY correlation of H-12 (d 4.03) with
the beta oriented H3-18 (d 0.84). The carbon signal at 86.8 ppm had
long-range correlations with H3-28 and H3-29 in the HMBC spec-
trum, readily assigned to C-3. Additionally, downfield shift of C-3
signal suggested that an oxygen bridge involving C-3 atom was
present in the framework. Resemblance of the spectral data of 4
with those of previously reported compounds (Feng et al., 2015)
together with the long-distance correlation of the quaternary car-
bon at 88.3 ppmwith H-3 (d 3.73) provided evidence for the oxygen
bridge between C-3 and C-10 carbons. The orientation of 3(10)-
epoxy bridgewas confirmed by inspecting the ROESY spectrum of 4
and calculating its minimized energy conformer byMM2molecular
mechanics program. In the ROESY spectrum, H-3 showed strong
correlationwith H3-28 (d 1.22), which in turn correlated with H-6b.
Moreover, a weak nOe correlation between H-3 and H3-29 was
observed. The minimized energy conformer of 4 clearly showed
that b-oriented 3(10)-epoxy bridge above the A ringmade H-3 to lie
in close proximity with H3-28 (2.45 Å) instead of alpha oriented H3-
29 (2.9 Å) (see Supplementary information: Fig. S36). For the alpha-
oriented epoxy bridge, completely conflicting interatomic distances
with the ROESY correlations were measured, revealing 3(10)b-
epoxy bridge. Thus, 4 was deduced to be 6a,12a,24(S),25-
tetrahydroxy-3(10)b-epoxy-9,10-seco-cycloartane-7,9(11)-dien-
16-one.
The compound 5 had a molecular formula of C31H50O5 based on
the HR-MS data (m/z 525.3566 [MþNa]þ, calcd for C31H50O5Na,
525.3555). An additional carbon suggested the insertion of amethyl
group into the structure. When 1D NMR spectra of 5 were
inspected, their similarities with those of 4 were acknowledged at
once. Major differences between these two compounds were that
the signals for the oxymethine at C-12 and the ketone resonance of
C-16 in 4 were missing, instead, additional signals for O-methyl
group (dH¼ 3.33 and dC¼ 56.5) were observed in 5 together with
hydroxylated C(H)-16 resonances as in the case of 1. The methoxy
protons at d 3.33 showed an HMBC correlation with d 79.2 (C-6),
suggesting that O-methylation occurred at C-6. Therefore, 5 was
identified as 16b,24(S),25-trihydroxy-6a-methoxy-3(10)b-epoxy-
9,10-seco-cycloartane-7,9(11)-diene.
The HR-MS spectrum of 6 (m/z 527.3370 [MþNa]þ, calcd for
C30H48O6Na, 527.3348) supported a molecular formula of C30H48O6.
The absence of 9,19-cyclopropane ring signals in the 1H NMR
spectrum suggested a ring cleavage as in 4 and 5. Five tertiary
methyl group signals observed in the up-field region, implying a
modification on one of the methyl groups compared to the starting
compound. An AB system at d 3.50 and 3.76 confirmed the presence
of a primary alcohol group. In the 13C NMR spectrum, apart from
the already expected carbon signals, two oxygen-bearing methine
carbons (d 68.7 and 89.1), two olefinic carbons (d 131.2 and 132.5)and a ketone carbonyl signal (d 221.9) were observed in the low-
field region. In the HSQC spectrum, no correlation were observed
between any protons with the carbons at d 131.2 and 132.5, justi-
fying a tetrasubstituted olefinic system. These olefinic signals were
attributed to C-9 and C-8, respectively, according to the HMBC
correlations from H-7, H-12 and H-19 to the signal at d 131.2, and
from H-7 and H-30 to d 132.5 resonance. The 3J-HMBC correlations
of the oxymethylene protons at d 3.50 and 3.76 with the C-8, C-14
and C-15 signals revealed the position of oxygenated methyl at C-
30. Finally, the HMBC correlation between H-15 with the carbon
resonance at d 221.9 confirmed the location of the ketone group to
be C-16. As a result, the structure of 6 was established as
6a,24(S),25,30-tetrahydroxy-3(10)b-epoxy-9,10-seco-cycloartane-
8(9)-en-16-one.
The molecular formula of 7 was established as C30H50O6 by HR-
MS analysis (m/z 529.3522 [MþNa]þ, calcd for C30H50O6Na,
529.3505). In the 1H NMR spectrum, the signals of a cyclopropyl
ring were not detected, implying a ring cleavage. In addition, the
hydroxymethine proton at C-16 was lost in the 1H NMR spectrum
compared to the starting compound. In the 13C NMR spectrum, a
signal observed at d 68.8 correlated with two proton resonances at
d 3.51 and 3.44 (AB system) in the HSQC spectrum, indicating the
presence of an oxymethylene group. On the other hand, a carbonyl
signal at d 221.8 was noticed from the 13C NMR spectrum together
with two olefinic carbon signals (d 132.3 and 136.6). In the HSQC
spectrum, no correlations of any protons with the olefinic carbons
indicated a tetrasubstituted olefinic system. The double bond was
located between C-9 and C-10 on the basis of the HMBC correla-
tions from H-1 and H-5 to the d 132.3 signal, as well as from H-1 to
the d 136.6 signal. Furthermore, the HMBC correlation between H2-
12 and C-19 suggested that the cyclopropane methylene carbon (C-
19) migrated over to C-11. The similarity between the spectral data
of 6 and previously reported biotransformation products of cyclo-
artanes not only supported our assumption but also helped us to
deduce the relative stereochemistry of C-19 to be b (Kuban et al.,
2010, 2013; Yang et al., 2012). Additionally, the long-range corre-
lations of H2-15 and H-17 with the carbonyl carbon at d 221.8
confirmed the oxidation of C-16(OH) to a ketone. Consequently,
metabolite 7 was deduced to be 3b,6a,16b,19,24(S),25-
hexahydroxy-ranunculan-9(10)-en-16-one.
The 1H and 13C NMR spectra of 8 were in agreement with those
reported for 3b,6a,16b,19,24(S),25-hexahydroxy-ranunculan-9(10)-
ene, previously obtained from the biotransformation study of CCG
with Cunninghamella blakesleeana NRRL 1369 (Bedir et al., 2015).
3. Conclusion
Despite their promising potential as biocatalysts, the use of
plant-associated endophytic fungi to transform plant originated
secondary metabolites have been scarcely explored. After pre-
liminary screenings, microbial transformation studies were carried
out using 15 endophytic fungi isolated from different parts of
Astragalus plants. Based on the analytical scale results, Alternaria
eureka 1E1BL1, a fungal species never exploited as a biocatalyst, was
selected for further biotransformation studies. Preparative scale
incubation of CCG with this endophytic fungus afforded eight
metabolites (1e8). A. eureka 1E1BL1 was found to be capable of
hydroxylation, oxidation, epoxidation, O-methylation, ring-
expansion and methyl migration reactions on the cycloartane nu-
cleus. These modifications resulted in the formation of the com-
pounds that would be difficult or impossible to prepare by
conventional synthetic methods.
Compounds 1, 2 and 3 were monohydroxylated analogs of CCG
having hydroxyl groups at C-12, C-17 and C-22 positions, respec-
tively, produced by P450-catalyzed monooxygenation reactions.
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positions. The presence of a hydroxyl group at aforementioned
positions has been rarely reported in the literature for triterpe-
noidal saponins (Lu et al., 2010; Shaymaa et al., 2016; Yoshikawa
et al., 2000). To the best of our knowledge, 17- and 22-
hydroxylation of cycloartane nucleus by microbial transformation
was never reported.
Apart from the monohydroxylation reactions, A. eureka 1E1BL1
catalyzed ring expansion and epoxidation reactions on CCG (4, 5
and 6) to form 3(10)b-epoxy-9,10-seco-cycloartane structure. The
microbial-catalysis of the B ring expansion reactions have been
observed in the transformation of cycloastragenol to give 9,10-seco-
cycloartane skeleton by the fungus Syncephalastrum racemosum AS
3.264 (Feng et al., 2015; Yang et al., 2012). However, a reaction
mechanismwas not proposed for this unique biotransformation. In
Fig. 4, a tentative reaction pathway is shown for compounds 4e6.
As cyclopropane ring behaves like a double bond in nature, C-1, C-5,
C-8 and C-11 positions are subject to allylic rearrangements. A
hydrogen abstraction from C-11 or C-8 by P450 enzyme results in
carbocation formation, which in turn leads tomigration of C-9/C-10
bond of the cyclopropane ring to yield a seven membered ring
(9,10-seco-cycloartane), C-8(C-9) or C-9(C-11) double bond and a
carbocation at C-10 position. As a result of this transformation, the
ring A favors boat conformation, which rearranges C-3(OH) and C-
10 to lie in close proximity (ca. 1.9e2.0 Å, calculated by minimized
energy conformers). This adjacent localization facilitates the
nucleophilic attack of C-3(OH) to the carbocation (C-10) to give
3(10)b-epoxy framework.
In addition, compounds 7 and 8 were the rearrangement
products of CCG resulting from the cleavage of 9,19-cyclopropane
ring followed by methyl migration. This unique transformation
was reported previously in the biotransformation of CA and CCG by
Cunninghamella blakesleeana NRRL 1369, SyncephalastrumFig. 4. The plausible mechanism for the traracemosum AS 3.264 and Alternaria alternata AS 3.4578 (Bedir et al.,
2015; Feng et al., 2015; Kuban et al., 2010; Yang et al., 2012).
Consequently, this is the first report in Astragalus sapogenin
chemistry utilizing Astragalus originated endophytic fungi. The
results of this study prove that biotransformation using endophytic
fungi is an efficient tool for the structural modification of secondary
metabolites to expand compound libraries and prediction of
tentativemammalianmetabolites of traditionally used crude drugs.4. Experimental
4.1. General experimental procedures
Mass spectrometry experiments were carried out on an Agilent
1200/6530 InstrumentHRTOFMS. NMR spectrawere recorded on
Varian Oxford AS400 and Bruker DRX-500 instruments. The
chemical shifts were measured relative to the residual solvent peak
and are expressed in d (ppm) and the coupling constant (J) are re-
ported in Hertz (Hz). Silica gel 60 (70e230 mesh, Merck), Sephadex
LH-20 (GE Healthcare Life Sciences) and RP-18 (Chromabond C18,
Macherey-Nagel) were used for column chromatography. TLC an-
alyses were carried out on Silica gel 60 F254 (Merck) and RP-18
F254s (Merck) plates. Spots were visualized under UV light and
by spraying with 20% H2SO4/water reagent followed by heating at
105 C for 1e2min.4.2. Plant material and the starting compound
Astragalus angustifolius and Astragalus condensatus (Fabaceae)
were collected from Spil Mountain (38 33.965’ N, 27 24.400’ E),
Manisa, Turkey in June 2013, and identified by Serdar G€okhan S¸enol
(Department of Biology, Faculty of Science, Ege University, Turkey).
The plant samples were put into plastic bags and transported to thensformation of compounds 4, 5 and 6.
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(CCG), was donated by Bionorm Natural Products Ltd. (_Izmir,
Turkey).4.3. Fungal material
The fungal endophytes used in this study were isolated from
fresh and healthy tissues of Astragalus species. The plant samples
were washed thoroughly in running tap water followed by distilled
water to remove any dirt and the adhering soil particles. Then, the
plant materials were cut into small pieces and were subjected to
surface sterilization under aseptic condition. The samples were
surface-sterilized by sequential immersion in 70% ethanol for
5min, %3e5 sodium hypochlorite for 5min, and 70% ethanol for
30 s. Finally, the surface-sterilized plant tissues were rinsed in
sterile distilled water three times for 1min, then air dried under a
laminar-flow hood. The outer tissues were removed from the air-
dried plant samples with the help of a flame-sterilized scalpel
and the inner tissues were cut into small fragments. The tissue
fragments were then placed in Petri dishes containing potato
dextrose agar (PDA), malt extract agar (MEA), Rose-Bengal Chlor-
amphenicol (RBC) agar and water agar (WA) and incubated at 25 C
until fungal growth started. To confirm the success of surface
sterilization procedure, 100 mL aliquots of water from the last
washing step were inoculated on PDA and incubated under the
same conditions in parallel. The plates weremonitored every day to
check the growth of endophytic fungi. The hyphal tips that emerged
from the tissue fragments were isolated and subcultured onto PDATable 1
1H NMR data of metabolites 1e7 (400MHz, in CD3OD).
H 1 2 3 4
dH(ppm), J (Hz) dH(ppm), J (Hz) dH(ppm), J (Hz) dH(ppm), J (Hz)
1 1.28m, 1.66m 1.26m, 1.58m 1.25m, 1.57m 1.38m, 1.58m
2 1.62m, 1.74m 1.61m, 1.70m 1.61m, 1.71m 1.74m, 2.00m
3 3.23 dd (10.8, 4.6) 3.32 dd (10.9, 4.4) 3.22 dd (4.4, 10.9) 3.73 d (5.6)
4
5 1.34m 1.33m 1.34 d (9.9) 1.61m
6 3.41m 3.45 dt (9.8, 3.3) 3.44m 4.54 dd (10.3, 3.4
7 1.35m, 1.41m 1.38m, 1.46m 1.35m, 1.41m 5.46 dd (3.5, 1.3)
8 1.64m 1.81 dd (12.1, 3.9) 1.78m
9
10
11 1.75 dd (9.3, 13.3),
2.0 dd (13.3, 5.1)
1.19m, 1.99m 1.16m, 2.09m 5.68 d (5.5)
12 3.82 dd (3.9, 5.9) 1.65m (2H) 1.44m, 2.11m 4.03 d (6.0)
13
14
15 1.41m, 2.02m 1.43m, 2.04m 1.41m, 2.15 dd (13.2,
8.5)
2.10 d (17.7), 2.45
(17.6)
16 4.46 ddd (5.4, 7.9,
7.9)
4.46 ddd (5.6, 7.6,
7.6)
4.19 dd (5.8, 8.2)
17 2.30 dd (11.0, 7.8) 2.08m 2.94 d (7.3)
18 1.10 s 1.18 s 1.23 s 0.84 s
19 0.47 d, 0.50 d (4.5) 0.38 d (4.3), 0.53 d
(4.1)
0.43 d (4.2), 0.51 d
(4.2)
2.67 d (14.3), 3.04
(14.0)
20 1.92m 2.11m 2.04m 1.73m
21 1.07 d (6.6) 0.92 d (6.4) 0.94 d (6.0) 1.09 d (6.8)
22 1.43m, 1.82m 4.04 dd (7.3, 5.8) 1.29m, 1.71m 1.56m, 1.90m
23 1.29m, 1.61m 1.58m, 1.77m 1.41m, 1.62m 1.41m, 1.59m
24 3.40m 3.53 dd (10.5, 2.2) 3.40m 3.30m
25
26 1.15 s 1.16 s 1.15 s 1.15s
27 1.17 s 1.22 s 1.16 s 1.17 s
28 1.24 s 1.22 s 1.24 s 1.22 s
29 0.95 s 0.95 s 0.96 s 1.12 s
30 1.02 s 0.99 s 1.28 s 1.32 s
10media. Subsequently, the pure fungal cultures were transferred on
PDA slants and stored at 4 C.
The endophytic fungus 1E1BL1 was identified by the identifi-
cation service at Deutsche Sammlung von Mikroorganismen und
Zellkulturen GmbH (DSMZ), Braunschweig, Germany. The identi-
fication of the fungal isolate was done on the basis of the sequence
of rDNA ITS, which is the first common DNA-barcode for fungi
(Schoch et al., 2012). Additionally, amplification and sequencing of
the large subunit of rDNA (LSU) and the TEF1 gene were performed
(Woudenberg et al., 2013). The assembled DNA sequences were
compared with those in GenBank, MycoID and various databases as
well as with the type species of Alternaria eureka (Pleosporaceae).4.4. Microbial transformation procedures
The microbial transformation process was conducted at two
scales; analytical and preparative. One-stage fermentation protocol
was followed where CCG was fed to the biotransformation media
72 h after the inoculation (Kuban et al., 2010). On analytical scale,
the mycelial agar plugs (8mm in diameter) from 5-day-old fungal
cultures grown on PDA plate were inoculated into 250ml Erlen-
meyer flask containing 50ml biotransformation medium (2%
glucose, 0.5% yeast extract, 0.5% NaCl, 0.5% Na2HPO4, 0.5% peptone
(w/v)) adjusted to pH 6.0. After inoculation, the flasks were incu-
bated on a rotary shaker at 180 rpm, 25 C for 72 h. CCG (10mg
dissolved in 500 ml of DMSO)was added to 72-h-old cultures, which
were then incubated at 25 C, 180 rpm for 21 days. The samples
were taken on days 0, 2, 4, 7, 10, 14, 17, 21 and centrifuged at5 6 7
dH(ppm), J (Hz) dH(ppm), J (Hz) dH(ppm), J (Hz)
1.32m, 1.49m 1.45m, 1.76m 1.83m, 2.31 d (14.4)
1.72m, 1.97m 1.67m, 2.05m 1.47m, 1.88m
3.72 d (5.6) 3.83 d (7.4) 3.36 dd (4.5, 11.2)
1.57 d (10.6) 1.50 d (9.6) 1.80m
) 4.05 dd (10.3, 2.8) 3.69 td (10.1, 2.7) 3.76 ddd (11.6, 7.2, 4.5)
5.36 brs. 2.21m, 2.57m 1.35m, 1.57m
2.45 d (10.9)
5.47 brs. 2.20m, 2.27m 3.04m
2.18 brs. (2H) 1.95m, 2.20m 1.51m, 1.86m
d 1.74m, 2.10 dd (12.9,
8.1)
2.46 s (2H) 1.97 d (19.7), 2.19 d (18.4)
4.55 ddd (5.6, 7.7, 8.0)
1.70m 2.72m 2.37 d (7.1)
0.87 s 1.07 s 1.07 s
d 2.55 d (13.9), 3.02 d
(13.6)
2.29 d (14.9), 2.75 d
(14.8)
3.51 dd (10.7, 5.0), 3.44 t
(11.1)
1.94m 1.84m 1.76m
0.97 d (6.4) 1.09 d (6.8) 1.06 d (6.8)
1.23m, 1.80m 1.59m, 1.92m 1.78m, 2.74m
1.43m, 1.63m 1.45m, 1.64m 1.39m, 1.58m
3.38 dd (10.9, 1.9) 3.36m 3.28m
1.15 s 1.21 s 1.14 s
1.17 s 1.24 s 1.17 s
1.15 s 1.20 s 1.17 s
1.07 s 1.18 s 0.68 s
0.97 s 3.50 d (11.4), 3.76 d
(11.4)
0.96 s
3.33 s
Table 2
13C NMR data of metabolites 1e7 (100MHz, in CD3OD).
C 1 2 3 4 5 6 7
dC (ppm) dC (ppm) dC (ppm) dC (ppm) dC (ppm) dC (ppm) dC (ppm)
1 33.7 t 33.5 t 33.5 t 38.8 t 38.5 t 40.3 t 31.9 t
2 31.1 t 31.1 t 31.1 t 25.8 t 25.7 t 26.5 t 32.8 t
3 79.4 d 79.5 d 79.4 d 86.8 d 86.8 d 87.9 d 78.4 d
4 42.7 s 42.7 s 42.7 s 48.3 s 48.0 s 46.5 s 42.5 s
5 54.6 d 54.5 d 54.7 d 63.6 d 62.8 d 64.9 d 57.8 d
6 70.3 d 69.8 d 70.3 d 68.9 d 79.2 d 68.2 d 68.5 d
7 39.3 t 38.9 t 39.3 t 136.8 d 130.5 d 40.7 t 37.4 t
8 49.6 d 48.8 d 51.0 d 141.8 s 145.7 s 132.5 s 40.9 d
9 22.0 s 22.2 s 22.2 s 134.2 s 132.8 s 131.2 s 132.3 s
10 30.7 s 30.7 s 31.1 s 88.3 s 88.6 s 89.1 s 136.6 s
11 39.7 t 27.0 t 27.4 t 128.4 d 127.6 d 30.76 t 39.3 d
12 73.7 d 34.0 t 28.0 t 72.3 d 39.3 t 30.82 t 33.7 t
13 50.5 s 47.8 s 51.6 s 48.7 s 45.0 s 47.0 s 42.7 s
14 47.3 s 46.5 s 47.1 s 46.9 s 50.9 s 51.0 s 46.5 s
15 50.2 t 48.5 t 49.3 t 49.8 t 45.3 t 42.1 t 49.8 t
16 73.2 d 73.1 d 82.5 d 221.4 s 72.8 d 221.9 s 221.8 s
17 49.8 d 53.3 d 89.3 s 57.2 d 57.0 d 62.7 d 63.2 d
18 18.5 q 19.2 q 21.0 q 18.6 q 17.2 q 19.2 q 18.1 q
19 32.3 t 31.8 t 32.6 t 41.5 t 41.4 t 39.1 t 68.8 t
20 29.4 d 35.4 d 35.7 d 32.8 d 30.0 d 33.0 d 32.7 d
21 16.0 q 13.4 q 14.2 q 18.5 q 18.6 q 19.6 q 19.5 q
22 33.8 t 75.3 d 30.5 t 33.6 t 33.8 t 33.9 t 29.4 t
23 28.5 t 34.9 t 29.2 t 29.9 t 28.5 t 30.0 t 29.9 t
24 78.3 d 79.1 d 78.0 d 79.5 d 78.5 d 79.5 d 79.4 d
25 73.8 s 73.5 s 73.8 s 73.8 s 73.8 s 73.8 s 73.8 s
26 25.4 q 25.1 q 25.4 q 25.1 q 25.4 q 25.1 q 25.1 q
27 25.5 q 25.6 q 25.4 q 25.6 q 25.4 q 25.6 q 25.6 q
28 29.0 q 28.8 q 29.0 q 23.4 q 25.4 q 24.9 q 26.5 q
29 16.0 q 15.8 q 15.9 q 25.3 q 25.2 q 27.2 q 14.8 q
30 21.9 q 20.5 q 23.0 q 28.7 q 26.1 q 68.7 t 18.1 q
10 56.5 s
G. Ekiz et al. / Phytochemistry 151 (2018) 91e98 9710000 rpm for 10min. Then supernatants were extracted with
EtOAc (1ml) and analyzed by TLC. Control experiments were con-
ducted in the absence of either CCG or the fungus. Preparative scale
biotransformation was performed in 1000ml Erlenmeyer flasks
each containing 300ml of biotransformation medium using
1080mg CCG, and incubated at 25 C, 180 rpm for 10 days. After
incubation period, the mycelia were filtered on a Buchner funnel,
the combined filtrate was extracted with EtOAc (5.5 L x 2), and the
organic phase was dried over anhydrous Na2SO4, followed by
filtration and evaporation in vacuo.4.5. Isolation and purification
After evaporation of the solvent in vacuo, 2.5 g of extract was
obtained due to the presence of unconsumed nutrients, as well as
undesired metabolic by-products of the fungus. The EtOAc extract
(2.5 g) was first chromatographed on a Sephadex-LH 20 column
(70 g) and eluted with 100% MeOH, which provided 80 fractions.
Fractions 38 to 48 were pooled together for further purification.
This fraction (1.90 g) was subjected to a reversed-phase column (C-
18, 100 g), using MeOHeH2O (45:55 to 90:10) and 100% MeOH
yielding 295 fractions. Fraction 66e80 (78mg) was submitted to
silica gel column (50 g) chromatography with the solvent system
CHCl3eMeOHeH2O (90:10:0.5 to 82.5:17.5:0.5) to give 3 sub-
fractions. Subfraction 1 (20mg) was further purified on a silica gel
column (10 g) using cyclohexane-EtOAc-MeOH (10:10:2) to afford
metabolite 6 (5mg). Fraction 94e100 (122mg) was chromato-
graphed over silica gel column (60 g) with the solvent system
CHCl3eMeOHeH2O (90:10:0.5 to 85:15:0.5) to provide 1 (22mg)
and 2 (5.5mg). Fraction 133e155 (82mg) was subjected to a silica
gel column (15 g), and eluted with CHCl3eMeOHeH2O (90:10:0.5
to 85:15:0.5) to give 8mg of 4. Fraction 169e185 (91mg) waspurified on a silica gel column (50 g) using CHCl3eMeOHeH2O
(90:10:0.5 to 85:15:0.5) to give metabolite 3 (22.2mg). Fraction
186e200 (135mg) was further fractionated over silica gel column
(55 g) with the solvent system CHCl3eMeOHeH2O (90:10:0.5 to
82.5:17.5:0.5) to give 20mg of metabolite 8. Fraction 201e210
(84mg) was chromatographed over silica gel column (50 g) with
the solvent system CHCl3eMeOHeH2O (90:10:0.5 to 85:15:0.5) to
give 4 subfractions. Subfraction 4 (14mg) was further purified on
silica gel column (10 g) using CHCl3eMeOHeH2O (90:10:0.5 to
85:15:0.5) to afford 7 (6.5mg). Fraction 285e295 (30mg) was
further applied to a silica gel column (30 g) using CHCl3eMeOH
(97.5:2.5 to 90:10) as eluent to purify 8mg of metabolite 5.
4.6. Spectral data of 1e7
Metabolite 1: 1H NMR (CD3OD, 400MHz): see Table 1; 13C NMR
(CD3OD, 100MHz): see Table 2; HR-MS: m/z 531.3664 [MþNa]þ
(C30H52O6Na, calcd. 531.3661).
Metabolite 2: 1H NMR (CD3OD, 400MHz): see Table 1; 13C NMR
(CD3OD, 100MHz): see Table 2; HR-MS: m/z 531.3679 [MþNa]þ
(C30H52O6Na, calcd. 531.3661).
Metabolite 3: 1H NMR (CD3OD, 400MHz): see Table 1; 13C NMR
(CD3OD, 100MHz): see Table 2; HR-MS: m/z 531.3672 [MþNa]þ
(C30H52O6Na, calcd. 531.3661).
Metabolite 4: 1H NMR (CD3OD, 400MHz): see Table 1; 13C NMR
(CD3OD, 100MHz): see Table 2; HR-MS: m/z 525.3206 [MþNa]þ
(C30H46O6Na, calcd. 525.3192).
Metabolite 5: 1H NMR (CD3OD, 400MHz): see Table 1; 13C NMR
(CD3OD, 100MHz): see Table 2; HR-MS: m/z 525.3566 [MþNa]þ
(C31H50O5Na, calcd. 525.3555).
Metabolite 6: 1H NMR (CD3OD, 400MHz): see Table 1; 13C NMR
(CD3OD, 100MHz): see Table 2; HR-MS: m/z 527.3370 [MþNa]þ
(C30H48O6Na, calcd. 527.3348).
Metabolite 7: 1H NMR (CD3OD, 400MHz): see Table 1; 13C NMR
(CD3OD, 100MHz): see Table 2; HR-MS: m/z 529.3522 [MþNa]þ
(C30H50O6Na, calcd. 529.3505).
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